Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study.
about
Brain structure and obesityThe Rationale for Insulin Therapy in Alzheimer's DiseaseType 2 diabetes and cognitive impairment: linking mechanismsLink between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatmentAlzheimer's disease and type 2 diabetes: multiple mechanisms contribute to interactionsChronic adjunction of 1-deoxynojirimycin protects from age-related behavioral and biochemical changes in the SAMP8 mice.Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapyGIGYF2 gene disruption in mice results in neurodegeneration and altered insulin-like growth factor signalingApolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner.The link between cardiovascular risk, Alzheimer's disease, and mild cognitive impairment: support from recent functional neuroimaging studies.Cardiomyocyte contractile dysfunction in the APPswe/PS1dE9 mouse model of Alzheimer's diseaseCognitive impairment in diabetic patients: Can diabetic control prevent cognitive decline?Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies.Interaction of APOE e4 and poor glycemic control predicts white matter hyperintensity growth from 73 to 76The neuropathology of probable Alzheimer disease and mild cognitive impairment.Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease.Human cerebral neuropathology of Type 2 diabetes mellitusApolipoprotein E genotype modifies the association between midlife lung function and cognitive function in old age.Type 2 diabetes as a risk factor for cognitive impairment: current insights.Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier status.The future of blood-based biomarkers for Alzheimer's disease.Long term exendin-4 treatment reduces food intake and body weight and alters expression of brain homeostatic and reward markers.Diabetes and cognitive outcomes in a nationally representative sample: the National Health and Aging Trends StudyDiabetes, related conditions, and dementia.Framingham Coronary Heart Disease Risk Score Can be Predicted from Structural Brain Images in Elderly Subjects.Ethnoracial differences in the clinical characteristics of Alzheimer's disease at initial presentation at an urban Alzheimer's disease center.Dementia risk factors for Australian baby boomers.Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention.The role of nutrition in Alzheimer's disease: epidemiological evidence.Smoking and Alzheimer's disease among Mongolian and Han Chinese aged 55 years and over living in the Inner Mongolia farming area of China.Associations between apolipoprotein E gene polymorphisms and Alzheimer's disease risk in a large Chinese Han population.A kernel machine method for detecting effects of interaction between multidimensional variable sets: an imaging genetics application.Interactive effects of apolipoprotein E4 and diabetes risk on later myelinating white matter regions in neurologically healthy older aged adultsDiabetes and cognitionNeuronal LRP1 regulates glucose metabolism and insulin signaling in the brainRisk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study.Insulin resistance predicts medial temporal hypermetabolism in mild cognitive impairment conversion to Alzheimer disease.Consequences of Aberrant Insulin Regulation in the Brain: Can Treating Diabetes be Effective for Alzheimer's Disease.Glycemia, Diabetes Status, and Cognition in Hispanic Adults Aged 55-64 YearsEmpirically Derived Trajectories to Dementia Over 15 Years of Follow-up Identified by Using Mixed Membership Models.
P2860
Q24644378-50C9CAA9-425F-40A0-9562-022345D78187Q26744834-B397EA1B-5DC5-4C51-B4AF-57B8075481A0Q26822993-822D96AD-E1CE-41A7-8B80-6E1EEAA22A9FQ26860246-5E8B8B6E-333B-40A9-97AD-96F81F181590Q26864965-88F6B8FD-B657-47A1-8398-FE5439839642Q27313788-1356B5C0-81FA-4556-BFD3-79E7824CF8F8Q28282855-A8E43282-4BF6-417D-BF93-012F0647F034Q28593816-B41C3A2C-EB62-4A57-A887-167A4E95355BQ30572801-AAC6DBB3-82B7-4351-B3BD-68D1E4C5B764Q30830414-898A2AED-6B8F-4777-8BAD-955DB863082DQ33473889-F22656F8-D508-474D-BF53-8BDB433100CCQ33603286-46955FC6-BF8C-4762-B16C-6006D4A3523BQ33607787-FCD7359A-417B-46C2-875B-EE17C346A8D2Q33611205-76B9B190-1E8E-4B46-8E7F-8734A6575F8EQ33616561-0F6212DE-17F1-402C-9E6C-105CAE669B64Q33619317-AF0A7B5D-F7DC-4FCB-9410-2816ECC0BD2AQ33710643-554AE910-4D98-4911-8C32-407DDE522D82Q33785104-C3C97166-6679-435A-810A-ABD23120B86EQ33857774-8B749CE1-4EFE-425B-9248-F6859553C167Q33927061-9FAE2FE6-4EBD-4B1C-8D5A-C3DEA3139D98Q34026317-BD1E6BDD-0011-4614-8EDE-975DB8185A74Q34068305-463D59D9-450F-43A2-BFEE-9498D0B7883BQ34349059-40A8A687-EDD2-47B9-955D-0A1C3BC1A150Q34361375-9073C043-A4E7-4F0C-9EC8-56B93EEBA0E5Q34597077-540A9807-A93D-4822-A21F-B2DD0B53109FQ34891484-78730825-09B8-4324-80F9-74A93285CFE1Q34976976-EB7BB523-F3FB-44A7-AC7B-47CD0BC191E4Q34991223-67BA2294-9C45-4DF5-B542-A9AA4E100E3BQ34999138-40756237-0E1C-4FF3-BA47-5C148E543A7CQ35020731-64875C14-7CC5-483B-86BF-ACF16839F3EAQ35063476-5ABE8B0B-072D-49B0-85EA-B1D59C0F3DF9Q35117929-266525C3-D2C6-4E4F-9D61-C7383EC6D65EQ35167347-193ADE41-C15C-468A-B017-E31B1C86AAABQ35207601-0312F03C-844D-4D5E-AC30-1D168882EAB5Q35307950-E9C84EE4-FBDF-4B3C-9E6B-BBA501213EB8Q35600588-6C6DA0CD-5711-4E33-92F1-696DA8BDF57AQ35630843-0ACE51F9-8310-4534-AF9F-53CEADE0D856Q35687048-41C56DCD-C1AD-4BD2-92E6-99358FBB0EFDQ35854991-6D687550-7731-47E6-AA08-DA7C12D32FD5Q35927794-0916C29F-BEC3-4330-80F5-FB525B45F193
P2860
Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Enhanced risk for Alzheimer di ...... Health Study Cognition Study.
@ast
Enhanced risk for Alzheimer di ...... Health Study Cognition Study.
@en
Enhanced risk for Alzheimer di ...... Health Study Cognition Study.
@nl
type
label
Enhanced risk for Alzheimer di ...... Health Study Cognition Study.
@ast
Enhanced risk for Alzheimer di ...... Health Study Cognition Study.
@en
Enhanced risk for Alzheimer di ...... Health Study Cognition Study.
@nl
prefLabel
Enhanced risk for Alzheimer di ...... Health Study Cognition Study.
@ast
Enhanced risk for Alzheimer di ...... Health Study Cognition Study.
@en
Enhanced risk for Alzheimer di ...... Health Study Cognition Study.
@nl
P2093
P50
P921
P1433
P1476
Enhanced risk for Alzheimer di ...... Health Study Cognition Study.
@en
P2093
Annette L Fitzpatrick
Fumiko Irie
Oscar L Lopez
Rita Peila
P356
10.1001/ARCHNEUROL.2007.29
P577
2008-01-01T00:00:00Z